Literature DB >> 33825145

3D fusion between fluoroscopy angiograms and SPECT myocardial perfusion images to guide percutaneous coronary intervention.

Haipeng Tang1, Robert R Bober2, Chen Zhao3, Chaoyang Zhang1, Huiqing Zhu4, Zhuo He3, Zhihui Xu5, Weihua Zhou6,7.   

Abstract

BACKGROUND: Percutaneous coronary intervention (PCI) in stable coronary artery disease (CAD) is commonly triggered by abnormal myocardial perfusion imaging (MPI). However, due to the possibilities of multivessel disease, serial stenoses and variability of coronary artery perfusion distribution, an opportunity exists to better align anatomic stenosis with perfusion abnormalities to improve revascularization decisions. This study aims to develop a multi-modality fusion approach to assist decision-making for PCI. METHODS AND
RESULTS: Coronary arteries from fluoroscopic angiography (FA) were reconstructed into 3D artery anatomy. Left ventricular (LV) epicardial surface was extracted from SPECT. The artery anatomy and epicardial surface were non-rigidly fused. The accuracy of the 3D fusion was evaluated via both computer simulation and real patient data. Simulated FA and MPI were integrated and then compared with the ground truth from a digital phantom. The distance-based mismatch errors between simulated fluoroscopy and phantom arteries were 1.86 ± 1.43 mm for left coronary arteries (LCA) and 2.21 ± 2.50 mm for right coronary arteries (RCA). FA and SPECT images in 30 patients were integrated and then compared with the ground truth from CT angiograms. The distance-based mismatch errors between the fluoroscopy and CT arteries were 3.84 ± 3.15 mm for LCA and 5.55 ± 3.64 mm for RCA. The presence of the corresponding fluoroscopy and CT arteries in the AHA-17-segment model agreed well with a Kappa value of 0.91 (CI 0.89-0.93) for LCA and a Kappa value of 0.80 (CI 0.67-0.92) for RCA.
CONCLUSIONS: Our fusion approach is technically accurate to assist PCI decision-making and is clinically feasible to be used in the catheterization laboratory. Future studies are necessary to determine if fusion improves PCI-related outcomes.
© 2021. American Society of Nuclear Cardiology.

Entities:  

Keywords:  Myocardial revascularization; fluoroscopy angiography; image fusion; myocardial perfusion imaging

Mesh:

Year:  2021        PMID: 33825145     DOI: 10.1007/s12350-021-02574-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   3.872


  3 in total

1.  Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients.

Authors:  He S Yang; Sabrina E Racine-Brzostek; Mohsen Karbaschi; Jim Yee; Alicia Dillard; Peter A D Steel; William S Lee; Kathleen A McDonough; Yuqing Qiu; Thomas J Ketas; Eric Francomano; P J Klasse; Layla Hatem; Lars F Westblade; Heng Wu; Haode Chen; Robert Zuk; Hong Tan; Roxanne Girardin; Alan P Dupuis; Anne F Payne; John P Moore; Melissa M Cushing; Amy Chadburn; Zhen Zhao
Journal:  medRxiv       Date:  2020-11-22

2.  Three-dimensional fusion of coronary arteries with myocardial perfusion distributions: clinical validation.

Authors:  Tracy L Faber; Cesar A Santana; Ernest V Garcia; Jaume Candell-Riera; Russell D Folks; John W Peifer; Andrew Hopper; Santiago Aguade; Joan Angel; J Larry Klein
Journal:  J Nucl Med       Date:  2004-05       Impact factor: 10.057

3.  Survival benefit of coronary revascularization after myocardial perfusion SPECT: The role of ischemia.

Authors:  Tali Sharir; Idan Hollander; Biatriz Hemo; Judith Tsamir; Nikolay Yefremov; Andrzej Bojko; Vitaly Prokhorov; Marina Pinskiy; Piotr Slomka; Katz Amos
Journal:  J Nucl Cardiol       Date:  2019-11-11       Impact factor: 5.952

  3 in total
  1 in total

1.  Development of an approach to extracting coronary arteries and detecting stenosis in invasive coronary angiograms.

Authors:  Chen Zhao; Haipeng Tang; Daniel McGonigle; Zhuo He; Chaoyang Zhang; Yu-Ping Wang; Hong-Wen Deng; Robert Bober; Weihua Zhou
Journal:  J Med Imaging (Bellingham)       Date:  2022-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.